Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression

Dipeptidyl peptidase-4 inhibitors (DPP4i) are antidiabetic medications that prevent cleavage of incretin hormones by dipeptidyl peptidase-4 (DPP4). DPP4 is ubiquitously expressed, and its hepatic DPP4 expression is upregulated under non-alcoholic steatohepatitis (NASH) conditions. We investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Minyoung, Shin, Eugene, Bae, Jaehyun, Cho, Yongin, Lee, Ji-Yeon, Lee, Yong-ho, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655829/
https://www.ncbi.nlm.nih.gov/pubmed/33173107
http://dx.doi.org/10.1038/s41598-020-75288-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655829/
https://www.ncbi.nlm.nih.gov/pubmed/33173107
http://dx.doi.org/10.1038/s41598-020-75288-y

Ejemplares similares